36.20
0.00%
Close of 9 Nov 2026, in TWD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Dv Biomed Co
Its shares trade on Taipei Exchange under the ticker 6539.TWO. It has been listed since 15 October 2015. In the fiscal year to 31 December 2025, it reported revenue of TWD 794.2m and net income of TWD 7.7m. At that date it held total assets of TWD 677.2m and shareholders' equity of TWD 507.4m.
DV Biomed Co., Ltd. engages in the research and development of stem cells, genomics, anti-cancer drug, and proteomics. The company is headquartered in Taipei City, Taipei. The company went IPO on 2015-10-15. The medical consumables include medical beauty equipment, instrument probes, injections and implantable fillers. The firm is also engaged in the rental of medical beauty equipment. The medical-grade maintenance products and medical consumables are mainly used in medical beauty related industries. The firm is also engaged in the beauty skin care business and stem cell new drug development business. The firm distributes products within domestic market and to overseas markets.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Biotechnology
- Listed since
- 15 Oct 2015
- Website
- dvbiomed.com ↗
Leadership
Pay as last reported
- Ms. Liqi ZhangChairman of the Board, since 2024
- Mingfeng HeChief Financial Officer
- Meixiu ChenGeneral Manager
- Mr. Qingjun HuangDeputy General Manager-Administration Division, since 2015
- Yujun ZhouHead of Finance, Head of Accounting
- Mr. Mingtong ChenDirector
- Mr. Chung-Liang LeeDirector
- Mr. Qunzhi ChenIndependent Director
- Peter HouIndependent Director
- Mr. Senxiong ZhangIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Dv Biomed Co Ltd focuses on stem cell research and anti-cancer drug development in the Health Care sector.
- The company offers medical beauty equipment and implantable fillers for the medical beauty industry.
- Dv Biomed Co Ltd distributes medical consumables domestically and internationally in the Health Care market.
Weaknesses
- The company's medical consumables are primarily used in the medical beauty related industries.
- Dv Biomed Co Ltd relies on domestic market distribution for its products.
- The firm's rental business for medical beauty equipment is limited to specific segments.
Opportunities
- Expanding into overseas markets for medical consumables and beauty skin care services.
- Growing demand for stem cell new drug development in the Health Care sector.
- Increasing use of proteomics in anti-cancer drug research and development.
Threats
- Competition in the medical beauty equipment rental market within Taipei City.
- Regulatory challenges in the anti-cancer drug development industry.
- Dependence on the domestic market for medical consumables distribution.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.